Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2005 | 09-2005 | 06-2005 | 03-2005 | 12-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,074 | -1,584 | -1,169 | -727 | -3,085 |
| Depreciation Amortization | 6 | 5 | 4 | 3 | 1,049 |
| Accounts receivable | N/A | -235 | N/A | N/A | N/A |
| Other Working Capital | 486 | -317 | -2 | 41 | 354 |
| Other Operating Activity | 168 | 368 | 65 | 24 | 146 |
| Operating Cash Flow | $-1,414 | $-1,763 | $-1,102 | $-659 | $-1,537 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $0 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 600 | 698 | 450 | N/A | N/A |
| Debt Repayment | -130 | -130 | -130 | N/A | -1,850 |
| Common Stock Issued | 1,787 | N/A | N/A | N/A | 4,203 |
| Other Financing Activity | -380 | 0 | 0 | 0 | -162 |
| Financing Cash Flow | $1,877 | $568 | $320 | $N/A | $2,190 |
| Beginning Cash Position | 1,371 | 1,371 | 1,371 | 1,371 | 717 |
| End Cash Position | 1,834 | 176 | 589 | 712 | 1,371 |
| Net Cash Flow | $463 | $-1,195 | $-782 | $-659 | $654 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,414 | -1,763 | -1,102 | -659 | -1,537 |
| Free Cash Flow | -1,414 | -1,763 | -1,102 | -659 | -1,537 |